Vergoeding 2020-2024 voor ATC-subgroep L02BA : Anti-oestrogenen
- Raming voor de totale Zvw-populatie
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| L02BA01 Tamoxifen | 1.364.500 | 1.271.500 | 1.476.300 | 1.638.800 | 1.688.600 |
| L02BA03 Fulvestrant (Faslodex ®) | 9.152.400 | 7.655.000 | 7.045.400 | 6.318.400 | 6.370.100 |
| Totaal | 10.516.900 | 8.926.500 | 8.521.700 | 7.957.200 | 8.058.700 |